Access cutting-edge pulmonary sarcoidosis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access pulmonary sarcoidosis specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary sarcoidosis treatment provided free
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Sponsor: Xentria, Inc.
Check if you qualify for this pulmonary sarcoidosis clinical trial in Minneapolis, MN
If you're searching for pulmonary sarcoidosis treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary sarcoidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.